Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alistair Henry

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Cell Biology|February 13, 2003
A tumor-associated beta 1 integrin mutation that abrogates epithelial differentiation controlRichard D Evans, Vivienne C Perkins, Alistair Henry, et al.
Biochemistry|March 3, 2004
Structure of an allosteric inhibitor of LFA-1 bound to the I-domain studied by crystallography, NMR, and calorimetryMatthew P Crump, Thomas A Ceska, Leo Spyracopoulos, et al.
Mabs|March 28, 2014
Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signalingStevan Shaw, Tim Bourne, Chris Meier, et al.
Biochimica Et Biophysica Acta. Biomembranes|December 18, 2019
Detergent-free extraction of a functional low-expressing GPCR from a human cell lineJuan Francisco Bada Juarez, Juan C Muñoz-García, Rosana Inácio Dos Reis, et al.
Protein Engineering, Design & Selection : PEDS|April 25, 2007
Alternative antibody Fab' fragment PEGylation strategies: combination of strong reducing agents, disruption of the interchain disulphide bond and disulphide engineeringDavid P Humphreys, Sam P Heywood, Alistair Henry, et al.
Frontiers in Immunology|July 24, 2023
Identification and characterisation of anti-IL-13 inhibitory single domain antibodies provides new insights into receptor selectivity and attractive opportunities for drug discoveryKayleigh Walker, Roberta Baravalle, Rachel Holyfield, et al.
Plos Biology|May 22, 2018
Insight into small molecule binding to the neonatal Fc receptor by X-ray crystallography and 100 kHz magic-angle-spinning NMRDaniel Stöppler, Alex Macpherson, Susanne Smith-Penzel, et al.
Science Translational Medicine|October 5, 2021
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal modelsBert Schepens, Loes van Schie, Wim Nerinckx, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Cell Biology|February 13, 2003
A tumor-associated beta 1 integrin mutation that abrogates epithelial differentiation controlRichard D Evans, Vivienne C Perkins, Alistair Henry, et al.
Biochemistry|March 3, 2004
Structure of an allosteric inhibitor of LFA-1 bound to the I-domain studied by crystallography, NMR, and calorimetryMatthew P Crump, Thomas A Ceska, Leo Spyracopoulos, et al.
Mabs|March 28, 2014
Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signalingStevan Shaw, Tim Bourne, Chris Meier, et al.
Biochimica Et Biophysica Acta. Biomembranes|December 18, 2019
Detergent-free extraction of a functional low-expressing GPCR from a human cell lineJuan Francisco Bada Juarez, Juan C Muñoz-García, Rosana Inácio Dos Reis, et al.
Protein Engineering, Design & Selection : PEDS|April 25, 2007
Alternative antibody Fab' fragment PEGylation strategies: combination of strong reducing agents, disruption of the interchain disulphide bond and disulphide engineeringDavid P Humphreys, Sam P Heywood, Alistair Henry, et al.
Frontiers in Immunology|July 24, 2023
Identification and characterisation of anti-IL-13 inhibitory single domain antibodies provides new insights into receptor selectivity and attractive opportunities for drug discoveryKayleigh Walker, Roberta Baravalle, Rachel Holyfield, et al.
Plos Biology|May 22, 2018
Insight into small molecule binding to the neonatal Fc receptor by X-ray crystallography and 100 kHz magic-angle-spinning NMRDaniel Stöppler, Alex Macpherson, Susanne Smith-Penzel, et al.
Science Translational Medicine|October 5, 2021
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal modelsBert Schepens, Loes van Schie, Wim Nerinckx, et al.
Pageof 1